Primary lymphoma of the spleen: clinical analysis of 23 cases.
- Author:
Rupeng ZHANG
1
;
Dianchang WANG
;
Qiang LI
;
Tao SUN
;
Xishan HAO
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Combined Modality Therapy; Drug Therapy; Female; Humans; Lymphoma; diagnosis; drug therapy; surgery; Male; Middle Aged; Retrospective Studies; Splenectomy; Splenic Neoplasms; diagnosis; drug therapy; surgery
- From: Chinese Journal of Surgery 2002;40(3):208-209
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the best diagnostic and therapeutic method for primary lymphoma of the spleen.
METHODSClinicopathologic features of 23 patients treated from January 1956 to August 1999 were analyzed retrospectively.
RESULTSAll patients but one for exploration only (96%) underwent resection of the tumor. They accepted chemotherapy after operation. 23 patients were confirmed pathologically. B-cell type non-Hodgkin's lymphoma was noted in 21 patients and T-cell letion in 2. According to Ahman's staging, 9 patients belonged to stage I, 8 stage II, and 6 stage III. The 5-year survival rates were 50%, 40% and 16% respectively.
CONCLUSIONSThe diagnosis of splenic lymphoma is dependent mainly on B-ultrasound examination and CT scanning. Splenectomy combined with chemotherapy may provide optimum therapy for patients with splenic lymphoma.
